Literature DB >> 3516191

The expression of ABH and Y blood group antigens in benign and malignant breast tissue: the preservation of the H and Y antigens in malignant epithelium.

P Vowden, A D Lowe, E S Lennox, N M Bleehen.   

Abstract

The ABO(H) and Y antigen status of epithelial cells from 45 breast carcinomas, 14 benign breast lesions and 7 normal breasts have been assessed using an indirect immunoperoxidase histochemical assay and a series of blood group specific monoclonal antibodies. All 20 A, AB and B group tumours had lost the A and B isoantigens, 13 of these tumours were however found to express H and Y antigens. Of 25 group O tumours 17 expressed the expected H and Y antigens. These findings were not dependent on the histological nature or the invasive characteristics of the tumour. Similar results were obtained when 28 metastases from breast carcinomas were examined, the H and Y antigens being identified in the tumour elements in 24 lymph nodes while we failed to identify either the A or B antigens. The development of breast malignancy appeared therefore to correlate best with the deletion of A and B glycosyl transferases. Normal breast tissue consistently expressed the expected blood group isoantigens. Areas of benign breast disease showed a more varied pattern of antigen expression. Seven of 14 lesions lacked ABH antigens, the loss of blood group structures could not however be correlated with any specific histological features and was not limited to the loss of A and B substances.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516191      PMCID: PMC2001362          DOI: 10.1038/bjc.1986.54

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Blood group MN antigens and precursors in normal and malignant human breast glandular tissue.

Authors:  G F Springer; P R Desai; I Banatwala
Journal:  J Natl Cancer Inst       Date:  1975-02       Impact factor: 13.506

2.  Glycoprotein metabolism in inflammatory and neoplastic diseases of the human colon.

Authors:  Y S Kim; R Isaacs
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

3.  Differentiation of HeLa cells with respect to blood group H antigen.

Authors:  C Pann; W J Kuhns
Journal:  Nat New Biol       Date:  1972-11-01

4.  Loss of epithelial blood group antigen-A during wound healing in oral mucous membrane.

Authors:  E Dabelsteen; O Fejerskov
Journal:  Acta Pathol Microbiol Scand A       Date:  1974-05

5.  Enzymic conversion of "H1-glycolipid" to A or B-glycolipid and deficiency of these enzyme activities in adenocarcinoma.

Authors:  K Stellner; S Hakomori; G S Warner
Journal:  Biochem Biophys Res Commun       Date:  1973-11-16       Impact factor: 3.575

6.  Early immunologic diagnosis and prognosis of carcinoma. Philip Levine Award Address.

Authors:  I Davidsohn
Journal:  Am J Clin Pathol       Date:  1972-06       Impact factor: 2.493

7.  Tissue antigens A, B and H in health and disease.

Authors:  I Davidsohn; R Stejskal
Journal:  Haematologia (Budap)       Date:  1972

8.  Isoantigens A, B, and H in benign and malignant lesions of the cervix.

Authors:  I Davidsohn; S Kovarik; L Y Ni
Journal:  Arch Pathol       Date:  1969-03

9.  Loss of isoantigens A, B and H in prostate.

Authors:  R K Gupta; R Schuster; W D Christian
Journal:  Am J Pathol       Date:  1973-03       Impact factor: 4.307

10.  THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE. III. THE A, B, AND H ANTIGENS IN EMBRYOS AND FETUSES FROM 18 MM IN LENGTH.

Authors:  A E SZULMAN
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

View more
  11 in total

1.  ABO blood group and breast cancer incidence and survival.

Authors:  Margaret A Gates; Mousheng Xu; Wendy Y Chen; Peter Kraft; Susan E Hankinson; Brian M Wolpin
Journal:  Int J Cancer       Date:  2012-02-10       Impact factor: 7.396

2.  Why do younger breast cancer patients with blood group O have favorable prognosis?

Authors:  Kadri Altundag
Journal:  Med Oncol       Date:  2017-05-23       Impact factor: 3.064

3.  Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN.

Authors:  Gary F Clark; Paola Grassi; Poh-Choo Pang; Maria Panico; David Lafrenz; Erma Z Drobnis; Michael R Baldwin; Howard R Morris; Stuart M Haslam; Sophia Schedin-Weiss; Wei Sun; Anne Dell
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

4.  Localization of binding sites of Ulex europaeus I, Helix pomatia and Griffonia simplicifolia I-B4 lectins and analysis of their backbone structures by several glycosidases and poly-N-acetyllactosamine-specific lectins in human breast carcinomas.

Authors:  N Ito; S Imai; S Haga; C Nagaike; Y Morimura; K Hatake
Journal:  Histochem Cell Biol       Date:  1996-09       Impact factor: 4.304

5.  Semiquantitative immunohistochemical studies of blood group antigen A, B, H, Le(a), Le(b) structures and Ii backbone chains in the normal human cervix and in cervical adenocarcinoma.

Authors:  N R Griffin; M Wells
Journal:  Histochem J       Date:  1993-03

6.  Antibody BNH9 detects red blood cell-related antigens on anaplastic large cell (CD30+) lymphomas.

Authors:  G Delsol; A Blancher; T al Saati; E Ralfkiaer; A Lauritzen; L Bruigères; P Brousset; F Rigal-Huguet; C Mazerolles; A Robert
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

7.  Thyroid blood group isoantigen expression: a parallel with ABH isoantigen expression in the distal colon.

Authors:  P Vowden; A D Lowe; E S Lennox; N M Bleehen
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

8.  The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.

Authors:  Varvara Vitiazeva; Jayesh J Kattla; Sarah A Flowers; Sara K Lindén; Pushpa Premaratne; Birgitta Weijdegård; Karin Sundfeldt; Niclas G Karlsson
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

9.  The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study.

Authors:  Izzet Dogan; Murat Ayhan; Mustafa Gurbuz; Ahmet Kucukarda; Esra Aydin; Yuksel Urun; Irfan Cicin; Pinar Saip
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

10.  A new monoclonal antibody (A46-B/B10) highly specific for the blood group H type 2 epitope: generation, epitope analysis, serological and histological evaluation.

Authors:  U Karsten; G Pilgrim; F G Hanisch; G Uhlenbruck; M Kasper; P Stosiek; G Papsdorf; G Pasternak
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.